60 Degrees Pharmaceuticals, Inc. financial data

Symbol
SXTP, SXTPW on Nasdaq
Industry
Pharmaceutical Preparations
Location
1025 Connecticut Avenue Nw, Suite 1000, Washington, DC
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 399 %
Quick Ratio 27.5 %
Debt-to-equity 33.4 %
Return On Equity -152 %
Return On Assets -113 %
Operating Margin -1.9K %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2.3M shares -60.4%
Common Stock, Shares, Outstanding 1.86M shares
Entity Public Float 11.6M USD
Common Stock, Value, Issued 186 USD -67.9%
Weighted Average Number of Shares Outstanding, Basic 2.44M shares +445%
Weighted Average Number of Shares Outstanding, Diluted 2.44M shares +445%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 502K USD +164%
Cost of Revenue 413K USD +56.9%
Research and Development Expense 4.47M USD +256%
General and Administrative Expense 5.11M USD -7.5%
Operating Income (Loss) -9.53M USD -39.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -7.95M USD -152%
Income Tax Expense (Benefit) 812 USD +297%
Net Income (Loss) Attributable to Parent -7.91M USD -152%
Earnings Per Share, Basic 2.72 USD/shares -110%
Earnings Per Share, Diluted 2.72 USD/shares -110%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.3M USD
Accounts Receivable, after Allowance for Credit Loss, Current 324K USD +135%
Inventory, Net 452K USD -24.4%
Assets, Current 6.89M USD -22.5%
Property, Plant and Equipment, Net 155K USD +3947%
Operating Lease, Right-of-Use Asset 13.5K USD +6.88%
Intangible Assets, Net (Excluding Goodwill) 264K USD +17.5%
Other Assets, Noncurrent 375K USD
Assets 7.42M USD -18.9%
Liabilities, Current 1.31M USD -47.2%
Liabilities 1.46M USD -44.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax 139K USD +71%
Retained Earnings (Accumulated Deficit) -38.5M USD -25.9%
Stockholders' Equity Attributable to Parent 6.04M USD
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 5.96M USD -8.49%
Liabilities and Equity 7.42M USD -18.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.14M USD -176%
Net Cash Provided by (Used in) Financing Activities 1.9M USD +944%
Net Cash Provided by (Used in) Investing Activities -9.81K USD -198%
Common Stock, Shares Authorized 150M shares
Common Stock, Shares, Issued 1.86M shares
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 752K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3.3M USD +48.8%
Deferred Tax Assets, Valuation Allowance 3.04M USD -8.85%
Deferred Tax Assets, Gross 3.74M USD +12.1%
Operating Lease, Liability 26.8K USD
Depreciation 8.15K USD -21%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -7.86M USD -151%
Lessee, Operating Lease, Liability, to be Paid 13.7K USD
Property, Plant and Equipment, Gross 299K USD +99.5%
Operating Lease, Liability, Current 529K USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 14K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 14K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.15 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 14K USD
Deferred Tax Assets, Operating Loss Carryforwards 3.45M USD +3.43%
Preferred Stock, Shares Issued 78.8K shares
Preferred Stock, Shares Authorized 1M shares 0%
Additional Paid in Capital 34.8M USD +28.1%
Preferred Stock, Shares Outstanding 78.8K shares
Amortization of Intangible Assets 10.3K USD +39.3%
Deferred Tax Assets, Net of Valuation Allowance 699K USD
Share-based Payment Arrangement, Expense 669K USD +21.8%
Interest Expense 2.29M USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%